A Randomized Controlled Clinical Trial of Thymoglobulin and Extended Delay of Calcineurin Inhibitor Therapy for Renal Protection After Liver Transplantation. A Multi-Center Study
Latest Information Update: 25 Sep 2021
At a glance
- Drugs Antithymocyte globulin (Primary) ; Calcineurin inhibitors; Ciclosporin; Corticosteroids; Mycophenolate mofetil; Tacrolimus
- Indications Liver transplant rejection
- Focus Therapeutic Use
- 05 Aug 2021 New trial record
- 27 Jul 2021 Primary endpoint (Change in (delta) creatinine from baseline to month-12) has not been met as per results published in the Transplantation
- 27 Jul 2021 Results published in the Transplantation